FreeCME

Through the Patient/Family Looking Glass: Perspectives in Treatment Planning by Disease Compartments for Pediatric Neuroblastoma

CME: 1.0

November 11, 2021
/ Print / Reprints /
| Share More
/ Text Size+

Target Audience

The educational design of this activity addresses the needs of pediatric oncology nurses, advanced practice providers (including nurse practitioners and physician assistants), pediatric oncologists, social workers, and other members of the team caring for children with pediatric neuroblastoma.

Statement of Need/Program Overview

With an ever-improving understanding of clinical and biological risk factors, treatment strategies for pediatric neuroblastoma have become more tailored based on risk stratification, predicted response, and risk of relapse. However, it is also important to consider treatment by compartmentalizing neuroblastoma and planning in concordance with the perspectives and goals of patients and their families.

Join a panel of experts for an in-depth discussion of pediatric neuroblastoma and its treatment across the continuum of care, treatment of bone/bone-marrow and CNS/leptomeningeal metastases, and use of new and emerging prognostic and predictive markers. Experts will also discuss the need to integrate patient and family perspectives into treatment planning to improve outcomes and enhance treatment and side-effect monitoring.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Integrate immunotherapeutic approaches for the management of pediatric neuroblastoma with bone and/or bone marrow involvement
  • Discuss minimal residual disease as a prognostic and predictive marker and implications for practice
  • Evaluate current and emerging treatment and monitoring strategies at diagnosis and relapse for patients with CNS/leptomeningeal metastases from neuroblastoma
  • Facilitate patient/family-centered strategies into treatment planning to optimize care and patient experience

Post a comment to this article